Desmopressin and bleeding risk after percutaneous kidney biopsy

Desmopressin and bleeding risk after percutaneous kidney biopsy

Abstract Background Desmopressin is used to reduce bleeding after kidney biopsy but evidence supporting its use is weak, especially in patients with elevated creatinine. The present study was undertaken to evaluate efficacy of desmopressin in reducing bleeding after percutaneous kidney biopsy. Metho...

Full description

Bibliographic Details
Main Authors: Ambarish Athavale, Hemant Kulkarni, Cagil D. Arslan, Peter Hart
Format: Article
Language:English
Published: BMC 2019-11-01
Series:BMC Nephrology
Subjects:
Desmopressin
Bleeding
Kidney biopsy
CKD
Online Access:http://link.springer.com/article/10.1186/s12882-019-1595-4

Internet

http://link.springer.com/article/10.1186/s12882-019-1595-4

Similar Items